ERBB2 and breast cancer: In mice, the deletion or inhibition of PTP1B attenuates the development of mammary tumors driven by mutant ErbB2 (HER-2) as well as their metastases, indicating that PTP1B plays an oncogenic role in the initiation of tumorigenesis [39,40,82].